1. Lu, Jun, Fu, Liang-Min, Cao, Yun, Liu, Zhi-Ping, Luo, Jun-Hang. 2023. LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway. In Oncogene, 42, 1543-1557. doi:10.1038/s41388-023-02666-x. https://pubmed.ncbi.nlm.nih.gov/36966254/
2. Lin, You-Sheng, Chang, Yung-Chi, Chao, Tai-Ling, Lee, Chih-Yuan, Hsu, Li-Chung. 2023. The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage. In The Journal of experimental medicine, 220, . doi:10.1084/jem.20220727. https://pubmed.ncbi.nlm.nih.gov/37158982/
3. Hu, Chonghui, Xia, Renpeng, Zhang, Xiang, Zheng, Shangyou, Chen, Rufu. 2022. circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis. In Molecular cancer, 21, 24. doi:10.1186/s12943-022-01501-3. https://pubmed.ncbi.nlm.nih.gov/35045883/
4. Lee, Chih-Yuan, Lai, Ting-Yu, Tsai, Meng-Kun, Lawrence, Toby, Hsu, Li-Chung. 2017. The ubiquitin ligase ZNRF1 promotes caveolin-1 ubiquitination and degradation to modulate inflammation. In Nature communications, 8, 15502. doi:10.1038/ncomms15502. https://pubmed.ncbi.nlm.nih.gov/28593998/
5. Hoxhaj, Gerta, Najafov, Ayaz, Toth, Rachel, Prescott, Alan R, MacKintosh, Carol. 2012. ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+/K+ATPase. In Journal of cell science, 125, 4662-75. doi:10.1242/jcs.110296. https://pubmed.ncbi.nlm.nih.gov/22797923/
智鼠故事 
